Welcome to our dedicated page for Sabra Health Care REIT SEC filings (Ticker: SBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sabra Health Care REIT, Inc. filings document the reporting obligations of a Nasdaq-listed healthcare REIT that owns and invests in healthcare real estate through subsidiaries. Its 8-K reports cover operating results, supplemental information packages, non-GAAP financial measure reconciliations, Regulation FD materials, capital-structure events and material definitive agreements.
Proxy materials describe board and shareholder governance for the Maryland corporation. Other disclosures address common stock listed under the SBRA symbol, equity distribution arrangements, debt redemption notices, related financing arrangements and risk or governance matters tied to the company’s REIT structure and healthcare real estate portfolio.
Sabra Health Care REIT, Inc. reported that Executive VP, CIO & Secretary Darrin Smith acquired 478 common stock units on February 27, 2026 as a grant/award. These units were credited as dividend-equivalent stock units based on the market value on the dividend payment date and carry no cash purchase price.
After this award, Smith directly holds 115,923 common shares/units, including 33,186 stock units that will settle one-for-one in Sabra common stock. The new dividend-equivalent units will vest and become payable on the same schedule as the original stock units they track.
Sabra Health Care REIT, Inc. Executive VP, CFO & Treasurer Michael Lourenco reported an acquisition of 4,005 shares of common stock on February 27, 2026. These reflect stock units credited as dividend equivalent payments on previously granted stock units under the 2009 Performance Incentive Plan and will vest and pay out on the same schedule as the related awards.
After this grant, he directly holds 461,521 shares of common stock, which includes 278,415 stock units that will settle one-for-one in common shares. He also has indirect holdings of 784 shares through his IRA and 207 shares through his spouse's IRA.
Sabra Health Care REIT, Inc. reported that Chair, CEO and President Richard K. Matros acquired 13,358 common stock units on February 27, 2026 as a grant or award. The units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carry no purchase price.
These stock units will vest and be paid in shares of common stock on the same schedule as the original awards, on a one-for-one basis. Following this acquisition, Matros directly holds 928,398 common shares, and indirectly holds 1,857,686 shares through the R&A Matros Revocable Trust.
Sabra Health Care REIT's Executive VP & CAO Jessica Flores reported equity compensation activity on February 10, 2026. She acquired 3,198 shares of common stock at $0 through vesting of funds-from-operations-based stock units granted under the 2009 Performance Incentive Plan.
On the same date, 1,172 shares were disposed of at $19.15 to satisfy tax withholding obligations related to restricted stock unit payouts. After these transactions, she directly owned 86,572 common shares, including 25,159 stock units that will settle one-for-one in common stock.
Sabra Health Care REIT, Inc. executive Darrin Smith reported performance-based equity awards and related tax share withholding. On February 10, 2026, he acquired 5,483 shares from FFO-based units and 14,088 shares from annual bonus PSUs, both vesting at no cash cost. The company withheld 2,927 and 6,390 shares at $19.15 per share to satisfy tax obligations. Following these transactions, he directly holds 115,445 shares of common stock, which includes 32,708 stock units payable one-for-one in shares upon settlement.
Sabra Health Care REIT, Inc.’s Executive VP, CFO & Treasurer Michael Lourenco Costa reported acquiring 22,848 shares of common stock on February 10, 2026 through vesting of performance-based stock units granted under the company’s 2009 Performance Incentive Plan.
The award was tied to funds-from-operations performance for the period from January 1, 2025 to December 31, 2025, with the compensation committee determining 90.8% of the target was earned, including 4,803 shares from dividend equivalents. Following this transaction, Costa directly beneficially owns 457,516 common shares, and the vested units are scheduled to be settled in shares on January 4, 2027, subject to earlier payment upon death, disability, or change of control.
Sabra Health Care REIT, Inc. Chair, CEO and President Richard K. Matros acquired 85,160 shares of common stock on February 10, 2026 at a price of $0 per share through the vesting of previously granted stock units. Following this award, he directly owns 915,040 common shares and indirectly holds 1,857,686 shares through the R&A Matros Revocable Trust.
The vested shares relate to funds from operations-based stock units granted on December 27, 2022. The Compensation Committee determined that 90.8% of the target performance for the period from January 1, 2025 to December 31, 2025 was achieved, triggering immediate vesting. The vested units will be settled on a one-for-one basis in common shares on January 4, 2027, subject to earlier settlement upon death, disability or change of control.
Sabra Health Care REIT, Inc. reports on its 2025 business as a diversified healthcare real estate investment trust focused on skilled nursing, senior housing, behavioral health and specialty hospitals in the U.S. and Canada.
As of December 31, 2025, Sabra owned 360 properties with 36,412 beds/units and undepreciated real estate investment of $5.9 billion, plus loans receivable and preferred equity totaling $442.4 million. No single tenant provided 10% or more of 2025 revenues, indicating broad credit diversification.
The portfolio includes 210 skilled nursing/transitional care, 119 senior housing (leased and managed), 16 behavioral health and 15 specialty hospital/other facilities. Sabra highlights growth drivers such as aging demographics and rising healthcare expenditures, while detailing risks including reimbursement pressure, labor shortages, regulatory changes, interest rates, inflation, pandemics and cybersecurity.
Sabra emphasizes an investment strategy centered on triple-net leases, senior housing managed structures, selective development, balance sheet liquidity of approximately $1.2 billion, and maintaining REIT status. As of February 4, 2026, market capitalization signals scale with 252,145,717 common shares outstanding and non‑affiliate equity value of $4.4 billion.
Sabra Health Care REIT reported fourth quarter 2025 diluted net income of $0.11 per share, with FFO of $0.36 and Normalized AFFO of $0.38 per share. Total revenue was $211.9 million, up from $182.3 million a year earlier, driven largely by its senior housing managed portfolio.
Same property managed senior housing Cash NOI rose 12.6% year over year in the quarter and averaged 15.0% growth for 2025. Sabra invested roughly $450 million in 2025 property acquisitions at an estimated 7.5% average initial cash yield and closed another $27.0 million after year-end.
The company has been awarded about $240 million of primarily managed senior housing and some skilled nursing investments at an estimated 8.0% initial cash yield. As of December 31, 2025, Net Debt to Adjusted EBITDA was 5.00x and liquidity totaled about $1.2 billion. The board declared a $0.30 quarterly dividend and issued 2026 guidance for net income of $0.60–$0.64 and Normalized AFFO of $1.55–$1.59 per diluted share.
State Street Corporation reported a significant but non-controlling stake in Sabra Health Care REIT Inc. common stock as of December 31, 2025. State Street beneficially owned 11,901,640 shares, representing 4.8% of the outstanding common stock.
The filing shows State Street had shared voting power over 9,941,754 shares and shared dispositive power over 11,901,640 shares, with no sole voting or dispositive power. State Street certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Sabra.